Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1995 2
1996 1
1999 1
2002 2
2004 2
2005 3
2006 2
2007 4
2008 5
2009 5
2010 3
2011 2
2012 6
2013 11
2014 4
2015 4
2016 4
2017 8
2018 2
2019 3
2020 2
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

67 results
Results by year
Filters applied: . Clear all
Page 1
Natural killer cell adoptive immunotherapy: Coming of age.
Baggio L, Laureano ÁM, Silla LMDR, Lee DA. Baggio L, et al. Among authors: silla lmdr. Clin Immunol. 2017 Apr;177:3-11. doi: 10.1016/j.clim.2016.02.003. Epub 2016 Feb 14. Clin Immunol. 2017. PMID: 26883680 Review.
Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial.
Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL, Parolo E, Pellegrini JAS, Viana MV, Schwarz P, Lisboa TC, Dora JMS, Portich JP, Paz AA, Silla L, Balsan AM, Schirmer FD, Franz JPM, da-Silveira LM, Breunig RC, Petersen V, Sosnoski M, Mesquita NF, Volpato FCZ, Sganzerla D, Falavigna M, Rosa RG, Zavascki AP; PLACOVID Study Group. Sekine L, et al. Among authors: silla l. Eur Respir J. 2021 Aug 12:2101471. doi: 10.1183/13993003.01471-2021. Online ahead of print. Eur Respir J. 2021. PMID: 34244316 Free PMC article.
Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.
Kennis BA, Michel KA, Brugmann WB, Laureano A, Tao RH, Somanchi SS, Einstein SA, Bravo-Alegria JB, Maegawa S, Wahba A, Kiany S, Gordon N, Silla L, Schellingerhout D, Khatua S, Zaky W, Sandberg D, Cooper L, Lee DA, Bankson JA, Gopalakrishnan V. Kennis BA, et al. Among authors: silla l. J Neurooncol. 2019 May;142(3):395-407. doi: 10.1007/s11060-019-03091-5. Epub 2019 Feb 20. J Neurooncol. 2019. PMID: 30788681
Human NK cells prime inflammatory DC precursors to induce Tc17 differentiation.
Clavijo-Salomon MA, Salcedo R, Roy S, das Neves RX, Dzutsev A, Sales-Campos H, Borbely KS, Silla L, Orange JS, Mace EM, Barbuto JAM, Trinchieri G. Clavijo-Salomon MA, et al. Among authors: silla l. Blood Adv. 2020 Aug 25;4(16):3990-4006. doi: 10.1182/bloodadvances.2020002084. Blood Adv. 2020. PMID: 32841340 Free PMC article.
Adoptive immunotherapy with double-bright (CD56bright /CD16bright ) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study.
Silla L, Valim V, Pezzi A, da Silva M, Wilke I, Nobrega J, Vargas A, Amorin B, Correa B, Zambonato B, Scherer F, Merzoni J, Sekine L, Huls H, Cooper LJ, Paz A, Lee DA. Silla L, et al. Br J Haematol. 2021 Dec;195(5):710-721. doi: 10.1111/bjh.17751. Epub 2021 Sep 7. Br J Haematol. 2021. PMID: 34490616 Clinical Trial.
67 results